Efficacy of c-Met inhibitor for advanced prostate cancer
© Tu et al; licensee BioMed Central Ltd. 2010
Received: 26 May 2010
Accepted: 14 October 2010
Published: 14 October 2010
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|26 May 2010||Submitted||Original manuscript|
|3 Jul 2010||Reviewed||Reviewer Report - Anthony Joshua|
|9 Jul 2010||Reviewed||Reviewer Report - Bo Lu|
|9 Jul 2010||Reviewed||Reviewer Report - Vasundara Venkateswaran|
|1 Sep 2010||Author responded||Author comments - William Tu|
|Resubmission - Version 2|
|1 Sep 2010||Submitted||Manuscript version 2|
|2 Sep 2010||Reviewed||Reviewer Report - Bo Lu|
|15 Sep 2010||Reviewed||Reviewer Report - Anthony Joshua|
|27 Sep 2010||Reviewed||Reviewer Report - Vasundara Venkateswaran|
|14 Oct 2010||Author responded||Author comments - William Tu|
|Resubmission - Version 3|
|14 Oct 2010||Submitted||Manuscript version 3|
|14 Oct 2010||Editorially accepted|
|14 Oct 2010||Article published||10.1186/1471-2407-10-556|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.